R&D Center

A Valuable choice for health and happiness.
A warm and sincere welcome to Megen’s R&D Center.

Regenerative medicine is an alternative treatment for intractable and rare diseases that have no adequate treatment methods, such as dementia, spinal cord injury and diabetes. This field has a great potential to grow into a new driving force in Korea’s future era of bio-economy, producing enormous economic values in different areas, such as personalized cell treatments, biological tissues and bio-organs.

Megen established its R&D Center in April 2021 for the advancement of regenerative medicine through basic and interdisciplinary research to a leader at home and abroad.

Megen established a bridgehead for the future medical service industry of Korea by developing biological tissues/organs using advanced biopolymer materials and concentrates its research capabilities to secure solid technological competitiveness by registering related patents.